PALO ALTO, Calif. – April 5, 2013 – Sciton, a leading manufacturer of high-quality custom, modular, multi-application medical laser and light systems for the aesthetic medical market, announces the introduction of CelluSmooth, an innovative laser module with proprietary M3 technology. CelluSmooth provides a minimally invasive treatment for cutting fibrous septae, emulsifying fat, and tightening* the dermis to improve the appearance of lumpy and dimpled skin.
The CelluSmooth procedure is a fast, effective, and safe treatment utilizing a proprietary M3 technology that allows the delivery of the 1319 nm laser wavelength in three distinct modes. CelluSmooth’s M3 technology enables physicians to treat the causes of lumpy and dimpled skin on the thighs, buttocks, stomach, and other areas of the body in a very short procedure time. “CelluSmooth produces long-lasting results that are equivalent to or better than other minimally invasive procedures on the market in one-half or one-third of the time,” says Dr. Marc J. Salzman, a board-certified plastic surgeon and founder of Salzman Institute of Cosmetic Surgery in Louisville, Kentucky. “This procedure results in a smoother appearance in troublesome areas such as the thighs and buttocks with minimal bruising and discomfort to our patients. We have very high patient satisfaction with this treatment.”
“Developed in conjunction with a panel of remarkable plastic surgeons and cosmetic physicians, CelluSmooth is the newest innovation in Sciton’s long line of laser technologies and represents a significant breakthrough in body contouring,” stated Dan Negus, Ph.D., President of Sciton. “It represents yet another step in our long commitment to our customers and their patients to continuously improve and introduce clinically safe and effective devices with no technically unnecessary consumables,” continued Dr. Negus.
CelluSmooth is available on the JOULE platform which offers multiple modules to treat many other indications, such as acne, permanent hair reduction, pigmented lesions, scar revision, skin texture improvement, and vascular lesions. This, combined with Sciton’s “no consumables” commitment, means physicians enjoy a maximum return on investment. It is just one of the reasons why Sciton was ranked as the #1 aesthetic laser device manufacturer in the March 2012 Physician Report published by Medical Spa MD (http://medicalspamd.com/). Readers interested in learning more about CelluSmooth can join a live webinar with Marc J. Salzman, MD, FACS on April 17th by registering at https://scitondev.wpengine.com/events. To discover more about Sciton and CelluSmooth, please visit http://ScitonCelluSmooth.com.
*Through Tissue Coagulation.
Sciton, Inc., located in Palo Alto, California, is a totally employee-owned medical device company established in 1997 by co-founders Jim Hobart, Ph.D., and Dan Negus, Ph.D. Sciton is committed to providing best-in-class laser and light solutions for medical professionals who want superior durability, performance, and value. Sciton offers aesthetic and medical devices for women’s health, fractional and full-coverage skin resurfacing and skin revitalization, phototherapy, vascular and pigmentation lesions, scar reduction, acne, body contouring, and hair reduction. Sciton operates worldwide with direct sales forces in the United States, Canada, Japan, Australia, and distributor partners in more than 45 countries. For more information and a complete listing of Sciton systems, visit sciton.com.